High call volumes
Our member and provider services may be experiencing higher than normal call volumes from 12/22/25-1/9/26 due to a large number of staff being out of office. We encourage you to utilize alternative forms of communication including secured messaging through online Member Services and Availity Essentials Provider Portal.
BCBSND district offices will be closed to the public on Friday, Dec. 26.
This includes Bismarck, Grand Forks, Jamestown and Minot. Need help? We’re here for you! Log in at BCBSND.me or call 844-363-8457.
We are unable to accept walk-ins on Friday, Dec. 26, and Friday, Jan. 2., due to short staffing.
This impacts our Commercial line of business only
Blue Cross Blue Shield of North Dakota (BCBSND) is seeing an increase of appeals related to GLP-1 antagonists. As of September 2024, the GLP-1 antagonists prior authorization program summary criteria includes the requirement of lab test results that confirms the patient’s type 2 diabetes diagnosis (e.g., A1C greater than or equal to 6.5%).
Please note, the lab value required is what prompted the type 2 diabetes diagnosis, not the most recent values. Providers must submit the required lab test results for patients to be considered for approval of coverage of diabetic GLP-1 agonists.
Questions?
Contact our Provider Service Center at 800-368-2312.
